Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting

American Journal of Cardiology

Volumn 91, Issue 2, 2003, Pages 154-158

  Ribichini, Flavio ^a,b,c,d   Wijns, William ^a,b,c,d   Ferrero, Valeria ^a,b,c,d   Matullo, Giuseppe ^a,b,c,d   Camilla, Terenzio ^a,b,c,d   Feola, Mauro ^a,b,c,d   Guarrera, Simonetta ^a,b,c,d   Vado, Antonello ^a,b,c,d   Piazza, Alberto ^a,b,c,d   Uslenghi, Eugenio ^a,b,c,d  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b OLV HOSPITAL   (Belgium)

^c UNIVERSITY OF TURIN   (Italy)

^d S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; CORONARY STENT; DIABETES MELLITUS; DNA POLYMORPHISM; ENZYME INHIBITION; FEMALE; FOLLOW UP; GENE DELETION; GENE INSERTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RESTENOSIS; STATISTICAL ANALYSIS;

ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY RESTENOSIS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS;

EID: 0037299591     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03101-6     Document Type: Article

References (11)

1. Meurice T., Bauters C., Hermant X., Codron V., VanBelle E., McFadden E.P., Lablanche J.M., Bertrand M.E., Amouyel P. Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS) a randomised, double-blind, placebo-controlled trial. Lancet. 357:2001;1321-1324.
2. Jorgensen E., Kelbaek H., Helqvist S., Jensen G.V.H., Saunamaki K., Kastrup J., Havndrup O., Bundgaard H., Madsen J.K., Christiansen M., Andersen P.S., Reiber J.H.C. Predictors of coronary in-stent restenosis importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 38:2001;1434-1439.
3. Ribichini F., Steffenino G., Dellavalle A., Matullo G., Colajanni E., Camilla T., Vado A., Benetton G., Uslenghi E., Piazza A. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme. A major risk factor and a marker of risk for coronary stent restenosis. Circulation. 97:1998;147-154.
4. Ohishi M., Ueda M., Rakugi H., Okamura A., Naruko T., Becker A.E., Hiwada K., Kamitani A., Kamide K., Higaki J., Ogihara Y. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans. Circulation. 96:1997;3328-3337.
5. Kondo J., Sone T., Tsuboi H., Mukawa H., Kosokabe T., Tsuzuki M., Tomida T., Suzuki T., Kamiya H., Hayashi K., Matsui H., Okumura K. Effect of quinalapril on intimal hyperplasia after coronary stenting as assessed by intravascular ultrasound. Am J Cardiol. 87:2001;443-445.
6. Peters S., Gotting B., Trummel M., Rust H., Brattstrom A. Valsartan for prevention of restenosis after stenting of type B2/C lesions the VAL-PREST trial. J Invasive Cardiol. 2:2001;93-97.
7. Lonn E.M., Yusuf S., Jha P., Montague T.J., Teo K.K., Benedict C.R., Pitt B. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Current perspective. Circulation. 90:1994;2056-2069.
8. Yusuf S., Sleiht P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 342:2000;145-153.
9. Kastrati A., Mehilli J., Dirschinger J., Pache J., Ulm K., Schuhlen H., Seyfarth M., Schmitt C., Blasini R., Neumann F.J., Schomig A. Restenosis after coronary placement of various stent types. Am J Cardiol. 87:2001;34-39.
10. Yu C.M., Tipoe G.L., Wing-Hon Lai K., Lau C.P. Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. J Am Coll Cardiol. 38:2001;1207-1215.
11. Soejima H., Ogawa H., Yasue H., Kaikita K., Takazoe K., Nishiyama K., Misumi K., Miyamoto S., Yoshimura M., Kugiyama K., Nakamura S., Tsuji I. Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction. J Am Coll Cardiol. 34:1999;983-988.